Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma

Ohio State University Comprehensive Cancer Center · 2006
ClinicalTrials.gov · Datasets · License: Public Domain · 2006
Open Source ↗
melanoma
renal cancer, melanoma, unresectable, metastatic, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 836524
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.